Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
180,181,824
-
Total 13F shares
-
63,567,962
-
Share change
-
+62,457,625
-
Total reported value
-
$201,611,000
-
Price per share
-
$3.17
-
Number of holders
-
37
-
Value change
-
+$198,091,000
-
Number of buys
-
35
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q4 2021
As of 31 Dec 2021,
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,567,962 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Rock Springs Capital Management LP, Foresite Capital Management V, LLC, Consonance Capital Management LP, CHI Advisors LLC, Vivo Capital, LLC, Avidity Partners Management LP, Monashee Investment Management LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.